Natural history of eosinophil‑derived neurotoxin levels and the onset of allergic airway disease in preschool children.
allergic airway disease
atopic march
eosinophil-derived neurotoxin
preschool children
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
27
04
2023
accepted:
15
06
2023
medline:
13
11
2023
pubmed:
13
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
'Atopic march' is the progression of allergic conditions through infancy and childhood. The present study investigated the association between blood eosinophil-derived neurotoxin (EDN) levels in preschool children with food allergy (FA) or atopic dermatitis (AD) and the onset of allergic airway disease [bronchial asthma (BA), allergic rhinitis (AR)]. A total of 123 children below the age of 1 year were enrolled in the present study, along with controls (n=37). Blood specimens were taken, serum EDN levels were measured and immunoglobulin E was quantified. Finally, a total of 86 subjects were analyzed. EDN values were measured at 3 time-points: before 1 year of age, before 2 years of age and before 3 years of age. The EDN levels were initially similar between those patients who did and those who did not develop allergic airway disease but then markedly diverged at the 2-year time-point (226.6 vs. 65.0 ng/ml; P<0.01) and remained divergent at the 3-year time-point (173.9 vs. 62.7 ng/ml; P<0.01). EDN levels prior to diagnosis were compared between the two groups and they were much higher in the Onset group (n=10) compared to the Non-onset group (n=67) (171.2±34.28 vs. 81.3±10.02 ng/ml; P=0.003), with 4 cases of BA and 6 cases of AR in the Onset group. After diagnosis, EDN levels were compared twice: i) At 1 and 2 years of age; and ii) 1 and 3 years of age. A significant difference was found only in the comparison at 2 years (P=0.001). In conclusion, young children with elevated EDN levels during the FA/AD disease period were more likely to develop allergic airway disease (BA, AR) in their first three years of life. A factor leading to this progression may be increased eosinophil activity.
Identifiants
pubmed: 37954115
doi: 10.3892/etm.2023.12264
pii: ETM-26-6-12264
pmc: PMC10632952
doi:
Types de publication
Journal Article
Langues
eng
Pagination
565Informations de copyright
Copyright © 2023, Spandidos Publications.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
PLoS One. 2018 Dec 19;13(12):e0208472
pubmed: 30566481
Allergy Asthma Immunol Res. 2018 Nov;10(6):686-697
pubmed: 30306750
Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 2):e697-704
pubmed: 20444156
Clin Exp Allergy. 1991 Sep;21(5):561-7
pubmed: 1742647
J Asthma. 2020 Nov;57(11):1211-1215
pubmed: 31298976
Int Arch Allergy Immunol. 2000 May;122(1):49-57
pubmed: 10859469
Allergy Asthma Immunol Res. 2017 Nov;9(6):466-476
pubmed: 28913985
JAMA Pediatr. 2015 Nov;169(11):e153219
pubmed: 26523822
PLoS One. 2012;7(8):e43214
pubmed: 22952649
Allergol Int. 2007 Dec;56(4):433-8
pubmed: 17965582
Pediatr Dermatol. 2016 Jul;33(4):388-98
pubmed: 27273433
J Asthma. 2010 Jun;47(5):568-73
pubmed: 20560830
J Dermatol Sci. 2001 May;26(1):79-82
pubmed: 11323224
Ann Allergy Asthma Immunol. 2018 Feb;120(2):131-137
pubmed: 29413336
J Allergy Clin Immunol Pract. 2023 Mar;11(3):750-761
pubmed: 36581068
Lung. 2007 Mar-Apr;185(2):97-103
pubmed: 17393238
JAMA. 2002 Aug 28;288(8):963-72
pubmed: 12190366
J Allergy Clin Immunol. 2018 Feb;141(2):601-607.e8
pubmed: 29153857
Allergy. 2004 Jan;59(1):26-32
pubmed: 14674929
Nat Rev Dis Primers. 2018 Jan 04;4:17098
pubmed: 29300005
J Allergy Clin Immunol. 2022 Jul;150(1):82-92
pubmed: 35150722
Allergol Int. 2017 Jan;66(1):70-74
pubmed: 27329145
Am J Respir Crit Care Med. 2000 Jan;161(1):64-72
pubmed: 10619799
BMC Pediatr. 2016 Aug 20;16:133
pubmed: 27542726
Clin Exp Allergy. 2002 Mar;32(3):361-6
pubmed: 11940064
Allergy. 2019 Oct;74(10):1835-1851
pubmed: 30953574
J Asthma. 2011 Dec;48(10):994-1000
pubmed: 22022864
Korean J Pediatr. 2015 Sep;58(9):330-5
pubmed: 26512258
Biomarkers. 2013 May;18(3):230-5
pubmed: 23557131
Clin Exp Allergy. 2008 May;38(5):709-50
pubmed: 18384431